Eli Lilly and Company
7-(METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE COMPOUNDS
Last updated:
Abstract:
The present invention provides a compound of Formula I: ##STR00001## wherein R is ##STR00002## or a pharmaceutically acceptable salt thereof, useful for treating psoriasis, systemic lupus erythematosus, or type 1 diabetes.
Status:
Application
Type:
Utility
Filling date:
5 Feb 2021
Issue date:
19 Aug 2021